Targeting Apoptotic Cell Death in Cancer Therapy: Chemotherapeutic Approaches

Clicks: 1
ID: 309247
2024
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #141 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
One of the main goals of contemporary oncological research is to generate more potent and less harmful medicines by focusing on apoptotic cell death in cancer therapy. This review article offers a thorough summary of chemotherapeutic strategies targeted at causing cancer cells to undergo apoptosis. It starts off by going over what is now known about apoptosis, including how it affects carcinogenesis and how chemotherapy works on it. Extrinsic and intrinsic routes, among other processes involved in apoptotic cell death, are clarified, emphasizing important molecular participants including caspases, the Bcl-2 family, and death receptors. The ubiquitin/proteasome system and methods for controlling apoptotic proteins, including as p53 and NF-κB, are also discussed in the study. It also covers specific methods of inducing apoptosis, such focusing on caspases and the Bcl-2 family, in addition to using TNF, TRAIL, and p53-based treatments. The study also offers insights into the state of preclinical and clinical research in apoptotic cancer treatment, as well as the assessment of new chemotherapeutic drugs that target different apoptotic pathways. All things considered, this review article provides insightful information on the many approaches and possible targets for boosting apoptotic cell death in cancer therapy, opening the door for the creation of more powerful therapeutic approaches.
Reference Key
imported_1761930129_6904eb91e9e8a Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Km. Bhumika
Journal International Journal of Pharmaceutical Drug Design (IJPDD)
Year 2024
DOI
10.62896/ijpdd.1.6.10
URL
https://ijpdd.org/index.php/files/article/view/137
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.